The global Cancer Biologics Market is estimated to be valued at US$ 94.5 Bn in 2023 and is expected to exhibit a CAGR of 7.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Cancer Biologics are monoclonal antibodies or proteins derived from living cells used to treat cancer. They work by precisely targeting specific cancer cells ... Read more
